September 13, 2016—House Energy & Commerce Health Subcommittee Republicans want to know how the 340B drug discount program has been affected by the EpiPen allergic emergency drug's apparent misclassification as a generic rather than brand name product for Medicaid rebate purposes. The GOP lawmakers raised the 340B matter among other questions in a Sept. 12 letter to the … [Read more...]
The 340B Drug Discount Program Explained
September 12, 2016—There's a lot of misinformation about The 340B program's purpose What it was designed to do Whether it's working as designed Whether it helps vulnerable patients Whether hospitals do enough to deserve drug discounts This great animated video by 340B Health answers all those questions and more in under two minutes. If you care about the … [Read more...]
Is Big Pharma Gaming the Orphan Drug System?
September 9, 2016—A new insurance industry study shows that almost half of the time orphan drugs are used for non-orphan indications. Not only that, it found that orphan drugs with the highest rates of non-orphan use are seeing the largest price increases. Such findings raise the question whether drug companies are gaming the orphan drug system to maximize its benefits while at … [Read more...]
How 340B Helped a Patient Get EpiPens She Couldn’t Afford
September 8, 2016—The EpiPen scandal is America's top healthcare story. Fortunately, hospitals in the 340B drug discount program are helping patients get EpiPens and other lifesaving medicines they otherwise couldn't afford. Here's a case in point from Wisconsin. … [Read more...]
Four Big 340B Mega-Guidance Concerns for Hospitals
September 7, 2016—Safety net hospitals and their patients will suffer if parts of the final 340B program mega-guidance remain unchanged from the Health Resources and Services Administration proposal last year. On Sept. 1, HRSA sent its final mega-guidance to the White House Office of Management and Budget for review before official release in the Federal Register. It looks … [Read more...]
Your Free Source for 340B News and Commentary
September 7, 2016—Welcome to 340B Informed. We're 340B Health's new blog and the successor to the Drug Discount Monitor newsletter. With interest in the 340B program growing, 340B Health felt it was important to make the material the Monitor covered free through 340B Informed to reach the widest audience. In addition to reporting the news, we'll put the news into context … [Read more...]
Final 340B Mega-Guidance Takes a Step Toward Release
September 2, 2016—The Health Resources and Services Administration has sent its final 340B program omnibus guidance to the White House Office of Management and Budget for review prior to publication in the Federal Register. HRSA transmitted the final mega-guidance to OMB on Sept. 1, according to an entry on an OMB website. OMB reviews all federal agency rules prior to their … [Read more...]